✦ LIBER ✦

Cell cycle-dependent fluctuation of urokinase-type plasminogen activator, its receptor, and inhibitors in cultured bovine mammary epithelial and myoepithelial cells

✍ Scribed by Boris Zavizion; Jeffrey H. White; Andrew J. Bramley

Book ID: 117350979
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 371 KB
Volume: 1403
Category: Article
ISSN: 0167-4889
DOI: 10.1016/s0167-4889(98)00035-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitation of urokinase-type plasminog

Quantitation of urokinase-type plasminogen activator receptor and its mRNA in tumor cell cultures

✍ H. Ihara; T. Urano; S. Urano; Y. Takada; A. Takada 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 147 KB

The significance of urokinase-type plasm

The significance of urokinase-type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

✍ Setsuko K. Chambers; Robert E. Gertz Jr.; Christina M. Ivins; Barry M. Kacinski 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Basal release of urokinase plasminogen a

Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells

✍ Christine Bruse; Yongmei Guan; Magdalena Carlberg; Kjell Carlström; Agneta Bergq 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Sodium butyrate differentially modulates

Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell

✍ Jennifer A. Reeder; Joanne L. Dickinson; Georgia Chenevix-Trench; Dr. Toni M. An 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 923 KB

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines

✍ Leif R. Lund 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Clinical relevance of urokinase plasmino

Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma

✍ Rainer Hofmann; Antonie Lehmer; Markus Buresch; Rudolf Hartung; Kurt Ulm 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

## BACKGROUND. Urokinase plasminogen activator (u-PA) plays a key role in the metastatic process by promoting plasmin mediated tissue degradation. Metastatic cell invasion requires localized proteolysis, which may be directed by u-PA receptor. The binding of u-PA and PAI-1 to the u-PA-receptor may